[go: up one dir, main page]

ES437008A1 - A PROCEDURE FOR THE PREPARATION OF BENZYL-PYRIMIDINE DERIVATIVES. - Google Patents

A PROCEDURE FOR THE PREPARATION OF BENZYL-PYRIMIDINE DERIVATIVES.

Info

Publication number
ES437008A1
ES437008A1 ES437008A ES437008A ES437008A1 ES 437008 A1 ES437008 A1 ES 437008A1 ES 437008 A ES437008 A ES 437008A ES 437008 A ES437008 A ES 437008A ES 437008 A1 ES437008 A1 ES 437008A1
Authority
ES
Spain
Prior art keywords
formula
procedure
preparation
benzyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES437008A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES437008A1 publication Critical patent/ES437008A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

A procedure for the preparation of benzylpyrimidine derivatives of the general formula **(See formula)** in which R1 and R2 each represent, in slope, a </p> group of C1-3alkyl, C1-3alkoxy, C2-3alkenyl or C2-3alkenyloxy, R4 represents a C1-3 alkyl or C2-3 alkenyl group, A represents an oxygen atom bonded to one of the cyclic nitrogen atoms and n has a value of 0 or 1, and its salts, the process of which comprises treating a compound of the formula **(See formula)** in which R1, R2, R4, A and n have the aforementioned meaning, with nitric acid, and convert if desired, a compound of formula I obtained into a salt. (Machine-translation by Google Translate, not legally binding)
ES437008A 1973-09-12 1975-04-25 A PROCEDURE FOR THE PREPARATION OF BENZYL-PYRIMIDINE DERIVATIVES. Expired ES437008A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1305773A CH591456A5 (en) 1973-09-12 1973-09-12

Publications (1)

Publication Number Publication Date
ES437008A1 true ES437008A1 (en) 1977-04-01

Family

ID=4388903

Family Applications (7)

Application Number Title Priority Date Filing Date
ES429949A Expired ES429949A1 (en) 1973-09-12 1974-09-11 A PROCEDURE FOR THE PREPARATION OF BENZYLPYRIMIDINE DERIVATIVES.
ES437011A Expired ES437011A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives
ES437012A Expired ES437012A1 (en) 1973-09-12 1975-04-25 A PROCEDURE FOR THE PREPARATION OF BENZYL-PYRIMIDINE DERIVATIVES.
ES437013A Expired ES437013A1 (en) 1973-09-12 1975-04-25 A PROCEDURE FOR THE PREPARATION OF BENZYL-PYRIMIDINE DERIVATIVES.
ES437008A Expired ES437008A1 (en) 1973-09-12 1975-04-25 A PROCEDURE FOR THE PREPARATION OF BENZYL-PYRIMIDINE DERIVATIVES.
ES437007A Expired ES437007A1 (en) 1973-09-12 1975-04-25 PROCEDURE FOR THE PREPARATION OF BENZYLPIRIMIDINE DERIVATIVES.
ES437009A Expired ES437009A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives

Family Applications Before (4)

Application Number Title Priority Date Filing Date
ES429949A Expired ES429949A1 (en) 1973-09-12 1974-09-11 A PROCEDURE FOR THE PREPARATION OF BENZYLPYRIMIDINE DERIVATIVES.
ES437011A Expired ES437011A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives
ES437012A Expired ES437012A1 (en) 1973-09-12 1975-04-25 A PROCEDURE FOR THE PREPARATION OF BENZYL-PYRIMIDINE DERIVATIVES.
ES437013A Expired ES437013A1 (en) 1973-09-12 1975-04-25 A PROCEDURE FOR THE PREPARATION OF BENZYL-PYRIMIDINE DERIVATIVES.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES437007A Expired ES437007A1 (en) 1973-09-12 1975-04-25 PROCEDURE FOR THE PREPARATION OF BENZYLPIRIMIDINE DERIVATIVES.
ES437009A Expired ES437009A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives

Country Status (28)

Country Link
JP (1) JPS6042238B2 (en)
AR (2) AR207764A1 (en)
AT (1) AT338797B (en)
BE (1) BE819773A (en)
BR (1) BR7407614D0 (en)
CA (1) CA1037476A (en)
CH (1) CH591456A5 (en)
CU (1) CU34115A (en)
DD (2) DD116824A5 (en)
DE (1) DE2443682C2 (en)
DK (1) DK135683B (en)
ES (7) ES429949A1 (en)
FI (1) FI58638C (en)
FR (1) FR2242984B1 (en)
GB (3) GB1484481A (en)
HK (1) HK181A (en)
HU (1) HU170427B (en)
IE (1) IE40523B1 (en)
IL (1) IL45510A (en)
LU (1) LU70878A1 (en)
NL (1) NL155827B (en)
NO (1) NO140858C (en)
PH (1) PH10643A (en)
PL (2) PL99159B1 (en)
SE (1) SE419443B (en)
SU (3) SU577987A3 (en)
YU (3) YU217874A (en)
ZA (1) ZA745317B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515948A (en) * 1973-09-12 1985-05-07 Hoffmann-La Roche Inc. 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines
EP0001633A1 (en) * 1977-10-18 1979-05-02 The Wellcome Foundation Limited Processes for preparing tri-heterocyclic substituted methanes and their conversion into further intermediates useful in the preparation of pharmacologically active compounds
CH639273A5 (en) * 1978-09-12 1983-11-15 Hoffmann La Roche DIURETIC MEANS.
DE3250132C2 (en) * 1981-11-09 1997-01-16 Mallinckrodt Veterinary Inc 2,4-Di:amino-5-benzyl-pyrimidine derivs. prepn.
FR2516081B1 (en) * 1981-11-09 1987-05-29 Wellcome Found SYNTHESIS OF BENZYLPYRIMIDINES AND INTERMEDIATES FOR THE SYNTHESIS
GB2180836A (en) * 1985-09-27 1987-04-08 William James Stephen Barker Sunscreen
US4900859A (en) * 1987-12-03 1990-02-13 Hoffman-La Roche Inc. Process for 4-dimethylamino-3,5-dimethoxybenzaldehyde
CA1300166C (en) * 1987-12-03 1992-05-05 Alfredo Guerrato Process for the preparation of a benzoic acid ester

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1103931B (en) * 1957-02-21 1961-04-06 Wellcome Found Process for the preparation of 2,4-diamino-5-benzylpyrimidine derivatives
US3485840A (en) * 1964-11-12 1969-12-23 Hoffmann La Roche 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes

Also Published As

Publication number Publication date
ES437007A1 (en) 1977-04-01
AU7263174A (en) 1976-02-26
GB1484483A (en) 1977-09-01
DE2443682C2 (en) 1983-11-10
NL7411685A (en) 1975-03-14
ES429949A1 (en) 1976-10-01
PL99159B1 (en) 1978-06-30
HK181A (en) 1981-01-16
FI58638B (en) 1980-11-28
IE40523B1 (en) 1979-06-20
CH591456A5 (en) 1977-09-15
IE40523L (en) 1975-03-12
DK135683C (en) 1977-11-14
YU217874A (en) 1982-06-18
BR7407614D0 (en) 1975-07-08
GB1484481A (en) 1977-09-01
FI256174A7 (en) 1975-03-13
YU37154B (en) 1984-08-31
AR207764A1 (en) 1976-10-29
GB1484482A (en) 1977-09-01
NO140858B (en) 1979-08-20
ZA745317B (en) 1975-11-26
LU70878A1 (en) 1976-08-19
CA1037476A (en) 1978-08-29
DD116824A5 (en) 1975-12-12
JPS5053385A (en) 1975-05-12
DK468374A (en) 1975-05-12
FR2242984A1 (en) 1975-04-04
DK135683B (en) 1977-06-06
DE2443682A1 (en) 1975-03-20
YU301680A (en) 1983-04-27
IL45510A (en) 1978-08-31
HU170427B (en) 1977-06-28
ES437011A1 (en) 1977-04-01
PL97757B1 (en) 1978-03-30
ATA735174A (en) 1977-01-15
SE419443B (en) 1981-08-03
SU609465A3 (en) 1978-05-30
AR211387Q (en) 1977-12-15
ES437013A1 (en) 1977-04-01
CU34115A (en) 1983-10-04
BE819773A (en) 1975-03-11
SU571189A3 (en) 1977-08-30
DD122785A5 (en) 1976-11-05
IL45510A0 (en) 1974-11-29
PH10643A (en) 1977-07-22
NL155827B (en) 1978-02-15
ES437012A1 (en) 1977-04-01
SE7411382L (en) 1975-03-13
ES437009A1 (en) 1977-04-01
CU21022L (en) 1981-09-09
AT338797B (en) 1977-09-12
FR2242984B1 (en) 1977-11-04
SU577987A3 (en) 1977-10-25
YU301580A (en) 1983-04-27
NO743271L (en) 1975-04-07
NO140858C (en) 1979-11-28
JPS6042238B2 (en) 1985-09-20
FI58638C (en) 1981-03-10
YU37153B (en) 1984-08-31

Similar Documents

Publication Publication Date Title
ES452063A1 (en) New benzhydrysulphinyl derivatives
ES483767A1 (en) PROCEDURE FOR PRODUCING N-ARYLSULFONYL-L-ARGININAMIDES
ES394370A1 (en) Pharmacologically active 3-piperazinyl-carbonyloxy-2-pyridyl-isoindolin-1-ones
ES437008A1 (en) A PROCEDURE FOR THE PREPARATION OF BENZYL-PYRIMIDINE DERIVATIVES.
ES411901A1 (en) PROCEDURE FOR THE PREPARATION OF LIQUID CRIS-TALINES ESTERS.
ES438283A1 (en) Crystalline adducts of carbamoyl sulphoxides and urea in a 1:3 ratio
ES403486A1 (en) Procedure for the preparation of piperazine derivatives. (Machine-translation by Google Translate, not legally binding)
ES440029A1 (en) 2-aminoindane derivatives
GB1150747A (en) Nitrogen-Containing Sulphonic Acids and Their Use in the Electrodeposition of Copper
ES419386A1 (en) Indenopyrrole derivatives
ES407866A1 (en) Preparation of n -diethylaminoethyl - 2 - methoxy- 5 - methyl sulphonylbenzamide
ES419739A1 (en) 2-aryl-amino-imidazoline-2 compounds
ES409217A1 (en) A PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 5-NITROIMIDAZOLE.
GB1299566A (en) Bis-basic ethers of 2,6- and 2,7-dihydroxyanthraquinones
ES421417A1 (en) Method of inhibiting a colour-forming reaction
ES387410A1 (en) Pyridoxine mono-esters
ES388464A1 (en) Phenoxyethylamines
ES402551A1 (en) A procedure for the preparation of piperazine derivatives. (Machine-translation by Google Translate, not legally binding)
ES402749A1 (en) A PROCEDURE FOR THE PREPARATION OF TIENO-DIACEPINE DERIVATIVES.
ES400623A1 (en) PROCEDURE FOR THE PREPARATION OF A PHARMA-CEUTIC COMPOSITION.
ES428011A1 (en) PROCEDURE FOR THE PREPARATION OF 2-AMINO-3,5-DIBROMO-BENZYLAMINE.
ES451655A1 (en) A procedure for the preparation of pyrimidine derivatives. (Machine-translation by Google Translate, not legally binding)
SE7510784L (en) WAY TO PRODUCE NEW, NITROGENIC, POLYCYCLIC ASSOCIATIONS
ES440767A2 (en) Phenylethylamine derivatives
ES482948A1 (en) Oxadiazolotriazine derivative